SB 1574: Prescription Drug Price Transparency
GENERAL BILL by Cruz
Prescription Drug Price Transparency; Prohibiting permits for prescription drug manufacturers and nonresident prescription drug manufacturers and for certain wholesale distributors of prescription drugs from being renewed unless specified requirements are met; providing reporting requirements for certain entities that engage in wholesale distributions of prescription drugs; providing requirements for notifications by manufacturers of prescription drug price increases under certain circumstances; providing additional requirements for contracts between pharmacy benefit managers and individual health insurers, group health insurers, and health maintenance organizations, respectively, etc.
Effective Date: 7/1/2022
Last Action: 3/14/2022 Senate - Died in Banking and Insurance
Bill Text: Web Page | PDF
Last Action: 3/14/2022 Senate - Died in Banking and Insurance
Bill Text: Web Page | PDF
Senate Committee References:
- Banking and Insurance (BI)
- Regulated Industries (RI)
- Appropriations (AP)
Bill History
| Date | Chamber | Action |
|---|---|---|
| 1/6/2022 | Senate |
• Filed |
| 1/12/2022 | Senate |
• Referred to Banking and Insurance; Regulated Industries; Appropriations -SJ 136 |
| 1/18/2022 | Senate |
• Introduced -SJ 136 |
| 3/12/2022 | Senate |
• Indefinitely postponed and withdrawn from consideration |
| 3/14/2022 | Senate |
• Died in Banking and Insurance |
